Other Species / Isoforms
  QSOX2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S11-p
AGAAVARsPGIGAGP
0 1
QSOX2 (human) AGAAVARsPGIGAGP S11-p
QSOX2 (mouse) AARAVARDPGAYARQ D10
QSOX2 (rat) AARAVARGPGADARR G26
S25-p
PALRARRsPPPRAAR
Upstream
0 36
Treatment
  • LRRK2-IN-1
QSOX2 (human) PALRARRsPPPRAAR S25-p
QSOX2 (mouse) PGAYARQPPSLRAAR P18
QSOX2 (rat) PGADARRPLSPQAAR P34
R109-m1
RALAGDVrDWASAIR
0 1
QSOX2 (human) RALAGDVrDWASAIR R109-m1
QSOX2 (mouse) RALAADVRDWAAAIR R103
QSOX2 (rat) RALAADVRDWAAAIR R119
K146-ub
YPTFRYFkAFtKEFt
0 1
QSOX2 (human) YPTFRYFkAFtKEFt K146-ub
QSOX2 (mouse) YPTFRYFKAFTKEFT K140
QSOX2 (rat) YPTFRYFRAFTKEFT R156
T149-ga
FRYFkAFtKEFttGE
0 1
QSOX2 (human) FRYFkAFtKEFttGE T149-ga
QSOX2 (mouse) FRYFKAFTKEFTTGE T143
QSOX2 (rat) FRYFRAFTKEFTTGE T159
T153-ga
kAFtKEFttGENFkG
0 1
QSOX2 (human) kAFtKEFttGENFkG T153-ga
QSOX2 (mouse) KAFTKEFTTGENFKG T147
QSOX2 (rat) RAFTKEFTTGENFKG T163
T154-ga
AFtKEFttGENFkGP
0 1
QSOX2 (human) AFtKEFttGENFkGP T154-ga
QSOX2 (mouse) AFTKEFTTGENFKGP T148
QSOX2 (rat) AFTKEFTTGENFKGP T164
K159-ub
FttGENFkGPDRELR
0 1
QSOX2 (human) FttGENFkGPDRELR K159-ub
QSOX2 (mouse) FTTGENFKGPDRELR K153
QSOX2 (rat) FTTGENFKGPDRELR K169
N218
VAIVFESNSSYLGRE
0 1
QSOX2 (human) VAIVFESNSSYLGRE N218
QSOX2 (mouse) HAIVFESnGSYVGRE N212-ng
QSOX2 (rat) HAVVFESNGSYVGRE N228
K246-ub
TRALDGDkAFLEKLG
0 1
QSOX2 (human) TRALDGDkAFLEKLG K246-ub
QSOX2 (mouse) SRALDTDKAFLGTLG K240
QSOX2 (rat) SRALDTDKAFLGTLG K256
S296-p
LPDVRKKsLPLPEKP
0 1
QSOX2 (human) LPDVRKKsLPLPEKP S296-p
QSOX2 (mouse) LPDVRKKSLFLPEKS S290
QSOX2 (rat) LPDVRKKSLSLPEKP S306
S309
KPHKEENSEIVVWRE
0 1
QSOX2 (human) KPHKEENSEIVVWRE S309
QSOX2 (mouse) KSNKEEKsEVVVWKE S303-p
QSOX2 (rat) KPNKEENSEVVIWKE S319
Y323-p
EFDKSKLytVDLESG
0 1
QSOX2 (human) EFDKSKLytVDLESG Y323-p
QSOX2 (mouse) EFDRAKLYTADLESG Y317
QSOX2 (rat) EFDRAKLYTADLESG Y333
T324-p
FDKSKLytVDLESGL
0 1
QSOX2 (human) FDKSKLytVDLESGL T324-p
QSOX2 (mouse) FDRAKLYTADLESGL T318
QSOX2 (rat) FDRAKLYTADLESGL T334
S578-p
YSADQGDssEGGTLA
Upstream
0 11
Treatment
  • metastatic potential
QSOX2 (human) YSADQGDssEGGTLA S578-p
QSOX2 (mouse) YSVDQGSPGEWEAQG P572
QSOX2 (rat) YSVDQGSPGEWEGMG P588
S579-p
SADQGDssEGGTLAR
0 3
QSOX2 (human) SADQGDssEGGTLAR S579-p
QSOX2 (mouse) SVDQGSPGEWEAQGR G573
QSOX2 (rat) SVDQGSPGEWEGMGR G589
S635-ga
SLDGKLQsLDGPGAH
0 1
QSOX2 (human) SLDGKLQsLDGPGAH S635-ga
QSOX2 (mouse) RLDLRLQSPQGPQAL S629
QSOX2 (rat) RLDLRLQSPQGPQTL S645
S662
DFSSLDMSLCVVLYV
0 1
QSOX2 (human) DFSSLDMSLCVVLYV S662
QSOX2 (mouse) GFSSLDMsLCVVLYV S656-p
QSOX2 (rat) GFSSLDMSLCVVLYV S672
S672
VVLYVASSLFLMVMY
0 1
QSOX2 (human) VVLYVASSLFLMVMY S672
QSOX2 (mouse) VVLYVASsLFLMIMY S666-p
QSOX2 (rat) VVLYVASSLFLMIMY S682